• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Otezla keeps growing

Anonymous

Guest
Despite everything I have thrown at them, despite their nonexistent managed care access, despite having specialty pharmacies on our side working against them, they keep growing their TRx every week.

This worries me now that our focus is on Novartis. How do they keep growing? They don't seem to be taking my business and Enbrel and Stelara are flat. Is it all MTX they are taking or what gives? They are growing with no reason.
 




Who cares. Their growth comes after our failures. We won the PBM game and that's all they get.

We now need our focus on crushing NVS's overpriced fungal infection causing IL product. They are a threat, not Otezla.

Let Otezla wallow in their non access world.
 












Celgene had a chance to hire me but they didn't call back after the phone screen.

They have no idea what I have done to them since.

You win with biologics pros, not models.